Abstract:OBJECTIVE:To study the kinetics of immune response in mice and human immunized with rHB vaccine or rHBsAg derived from yeast cells (Hansenula polymorpha).METHODS:With different doses,the level of IFN-gamma secreted by spleen mononuclear cells (MNC) including CD8+ T cells by MACs of mice were detected by enzyme-linked immunospot (ELISPOT) methods after stimulation in vitro with HBsAg MHC class I peptide S28-39, respectively. At serial time points, the immunized mice were detected for IFN-gamma by ELISPOT as above and for the lymphocytotoxicity test (CTL) by specific lysis assay. The levels of IFN-gamma, IL-2, IL-5 and anti-HBs in mice induced by rHB vaccine were detected after single or three doses. Four adults were vaccinated with rHB vaccine according to 0, 1 and 2 month schedule. The peripheral blood mononuclear cells (PBMCs) were collected at the 3, 8, 21, 34 and 65 days after the first dose. The CD8+ T cells with high purity obtained by sorting from PBMCs were stimulated with rHBsAg or HBsAg peptides. The SFC of IFN-gamma, IL-2 and IL-4 of CD4+ and CD8+ T cells were determined by ELISPOT.RESULTS:The cytokine of IFN-gamma became detectable on day 7 and its peak value appeared on day 14 by ELISPOT. The CTL was detected on day 7 and the maximum lysis of CTL appeared on day 28. The cellular immune response of IFN-gamma of MNCs were significantly correlated with the doses vaccinated from 1 microg to 8 microg (r(positive rates) = 0.951, P(positive rates) = 0.049 < 0.05; r(SFC) = 0.996, P(SFC) = 0.000 < 0.05). IFN-gamma SFC of CD+ T cells were significantly associated with the doses from 1 microg to 4 microg (r = 0.999, P = 0.025 < 0.05). The HBsAg specific cellular immune an d humoral responses of mice immunized with three doses were significantly higher than that with a single dose (P < 0.05). The characteristics of IFN-gamma, IL-2 and IL-4 of CD4+ and CD8+ T cells were variable between individuals immunized with the same rHB vaccine. The level of IL-2 and IL-4 of responders were significantly related to the titer of anti-HBs.CONCLUSION:Data from this study showed the kinesis of cellular immunity in mice and adults vaccinated with rHBsAg or rHB vaccine respectively, and the characteristics of cellular immune response in adults induced by the vaccine. Our data provided the basis of standardizing the analysis of cellular immune response to rHB vaccine.

Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Immunological Effects of a 10-Μg Dose of Domestic Hepatitis B Vaccine in Adults

Comparative Immunogenicity of a High-Dose Hepatitis B Virus (HBV) Vaccine with Rapid Immunization vs. Standard Schedule in HBV Vaccine—Naïve Adults Aged 25–55 in China

Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

The Response of Hepatitis B Vaccination on Seronegative Adults with Different Vaccination Schedules.

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines

The One Year Effects of Three Doses of Hepatitis B Vaccine As a Booster in Anti-Hbs-negative Children 11–15 Years after Primary Immunization; China, 2009–2011

Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques

Suitable Hepatitis B Vaccine for Adult Immunization in China

Antibody reaction to immunization with recombinant hepatitis B vaccine in undergraduates

Comparison of hepatitis B vaccine efficacy in Japanese students: a retrospective study

[Cellular Immune Responses of Recombinant Hepatitis B (rhb) Vaccine and HBsAG Derived from Hansenula Polymorpha Cells].

Comparison of Hepatitis B Surface Antibody Levels After Vaccination With Combined One Dose of Hexavalent Vaccine and Two Doses of Pentavalent Vaccine Versus Three Doses of Pentavalent Vaccine

Strategies for Hepatitis B Booster Vaccination among Children: an 8-Year Prospective Cohort Study

Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers

Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children

Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults

[Study on the Kinesis of Cellular Immunity in Adults Vaccinated with Recombinant Hepatitis B Vaccine].

Liposome-loaded Dissolvable Microneedle Patches for More Efficient Intradermal Antigen Delivery of Hepatitis B Vaccine